Omeprazole and clopidogrel: Should clinicians be worried?

Cleveland Clinic Journal of Medicine
Jeremiah P Depta, Deepak L Bhatt

Abstract

The US Food and Drug Administration has issued a warning that omeprazole (Prilosec) reduces the antiplatelet activity of clopidogrel (Plavix) by about 50%. However, the warning is based largely on ex vivo data. Preliminary results from a randomized clinical trial revealed no effect on cardiovascular outcomes when omeprazole was given with clopidogrel. We recommend that physicians continue to prescribe a proton pump inhibitor for patients receiving dual antiplatelet therapy who are at risk of gastrointestinal bleeding or have an indication for use of a proton pump inhibitor.

Citations

Feb 22, 2012·Journal of Cardiovascular Translational Research·Atif MohammadSubhash Banerjee
Oct 12, 2010·The New England Journal of Medicine·Deepak L BhattUNKNOWN COGENT Investigators
Apr 13, 2011·The Journal of Cardiovascular Nursing·Kathy BerraEileen Handberg
Oct 30, 2010·Stroke; a Journal of Cerebral Circulation·Christopher D AndersonJonathan Rosand
Feb 20, 2014·Indian Journal of Pharmacology·Vikram K MahajanVikas Sharma
Apr 12, 2013·Mediators of Inflammation·Mau SinhaTej P Singh
Oct 19, 2012·Current Opinion in Cardiology·Jeremiah P Depta, Deepak L Bhatt
Dec 12, 2012·Journal of Digestive Diseases·Carla J Gargallo, Angel Lanas
Oct 12, 2010·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Deepak L Bhatt
Jul 22, 2014·Journal of Clinical Pharmacology·Sudharshan HariharanRajanikanth Madabushi
Mar 26, 2016·Journal of the American College of Cardiology·Muthiah VaduganathanUNKNOWN COGENT Investigators
Jun 24, 2010·The American Journal of Medicine·Joseph S AlpertGordon A Ewy
Jul 16, 2010·JACC. Cardiovascular Interventions·Nihar R Desai, Deepak L Bhatt
Jan 7, 2015·Annual Review of Pharmacology and Toxicology·Jeremiah P Depta, Deepak L Bhatt
May 5, 2016·The American Journal of Medicine·Muthiah VaduganathanUNKNOWN COGENT Investigators
Oct 7, 2010·Journal of Cardiovascular Pharmacology and Therapeutics·Krishna G Aragam, Deepak L Bhatt
Sep 11, 2010·Expert Opinion on Pharmacotherapy·Mariano A GiorgiClaudio D González
Apr 14, 2016·Molecular Biology Reports·Mohammed JarrarKhaled Moustafa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.